newsfilter
← Latest News
PR Newswire·

Akcea Appoints New Senior Vice President, Business Development and Corporate Strategy

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced that Kia Motesharei, Ph.D., has...